(secondQuint)Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC.

 The results of our preliminary pilot study suggested that sorafenib combined with hepatic arterial infusion chemotherapy (HAIC) may improve the survivals for advanced stage HCC.

 Thus, the investigators carried out this prospective randomized control study to find out it.

.

 Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC@highlight

The purpose of this study is to evaluate the efficacy and safety of sorafenib combined with hepatic arterial infusion chemotherapy (HAIC) compared with sorafenib Alone in patients with hepatocellular carcinoma (HCC) with major portal venous tumor thrombus (PVTT).

